Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Talphera, Inc. (TLPH) vs Zhengye Biotechnology Holding Limited (ZYBT)

Talphera, Inc. and Zhengye Biotechnology Holding Limited are both Drug Manufacturers Specialty & Generic companies. Talphera, Inc. is the larger, with a market value of $60.7M against $40.1M — 1.5× the size. Across the 7 metrics below, Zhengye Biotechnology Holding Limited leads on 4 and Talphera, Inc. on 3.

Valuation

Metric TLPH ZYBT Drug Manufacturers Specialty & Generic median
P/E n/m — 20.14
P/S 209.21 — 2.25
P/B 6.19 n/m 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA n/m n/m 12.29
EV/Sales 183.86 n/m 2.56
Earnings yield (22.88%) — (2.99%)
Free cash flow yield (10.82%) 0.00% 0.00%

Profitability

Metric TLPH ZYBT Drug Manufacturers Specialty & Generic median
Gross margin 100.00% — 53.94%
Operating margin 0.00% — 0.00%
Net margin 0.00% — 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (143.36%) 0.00% (0.40%)
Return on assets (69.60%) 0.00% (3.32%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric TLPH ZYBT Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (73.07%) — 10.01%
EPS growth (last fiscal year) 32.00% (800.00%) —
Revenue growth, 5-year CAGR (58.55%) — 6.74%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric TLPH ZYBT Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.24 0.05
Current ratio 4.29 1.14 2.31
Net debt to EBITDA 1.50 (0.51) 0.85

Dividend

Metric TLPH ZYBT Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 — 0.00

Size

Metric TLPH ZYBT Drug Manufacturers Specialty & Generic median
Market cap 60.73m 40.13m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack